World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
13590
World Ranking
3038
National Ranking
1424

Don J. Diamond publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Don J. Diamond sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 228 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Don J. Diamond D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Don J. Diamond sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Don J. Diamond is affiliated with the City Of Hope National Medical Center in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on several subfields including Infectious Diseases, Epidemiology, Immunology, Oncology, and Molecular Biology.

The scientist's work covers multiple topics, notably:

  • Cytomegalovirus and herpesvirus research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immunotherapy and Immune Responses
  • Herpesvirus Infections and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction

Frequent co-authors collaborating with Don J. Diamond include:

  • Flavia Chiuppesi
  • Teodora Kaltcheva
  • Qiao Zhou
  • Felix Wussow
  • Corinna La Rosa

The scientist has published multiple papers in venues where they have several appearances, such as npj Vaccines, bioRxiv (Cold Spring Harbor Laboratory), Transplantation and Cellular Therapy, Frontiers in Immunology, and iScience.

Recent publications include:

  • Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids, 2020, Cell Reports Medicine
  • Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform, 2020, Nature Communications
  • Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients, 2020, Annals of Internal Medicine
  • Personal Protective Equipment and COVID-19, 2020, Annals of Surgery
  • Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates, 2022, npj Vaccines

Best Publications

  • Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection

    Don J. Diamond;Joanne York;Ji-Yao Sun;Christine L. Wright

  • Unusual organization and diversity of T-cell receptor a-chain genes

    Adrian C. Hayday;Adrian C. Hayday;Don J. Diamond;Gary Tanigawa;Joseph S. Heilig

  • The immune response to human CMV

    Corinna La Rosa;Don J Diamond

  • CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.

    Frank Cichocki;Sarah Cooley;Zachary Davis;Todd E. DeFor

  • Regulation of growth hormone messenger RNA synthesis by dexamethasone and triiodothyronine: Transcriptional rate and mRNA stability changes in pituitary tumor cells

    Don J. Diamond;Howard M. Goodman

  • Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients

    Wendi Zhou;Jeff Longmate;Simon F. Lacey;Joycelynne M. Palmer

  • Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.

    Dongchang Zhao;Darya Alizadeh;Leying Zhang;Wei Liu

  • Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.

    Laura L. Gibson;Giampiero Piccinini;Daniele Lilleri;Maria Grazia Revello

  • Lack of association of cytomegalovirus with human brain tumors.

    Sean K Lau;Yuan-Yuan Chen;Wen-Gang Chen;Don J Diamond

  • Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes

    Longmate J;York J;La Rosa C;Krishnan R

  • Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.

    Felix Wussow;Flavia Chiuppesi;Joy Martinez;John Campo

  • Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant

    Corinna La Rosa;Jeff Longmate;Simon F. Lacey;Teodora Kaltcheva

  • Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides.

    Ludmila Krymskaya;Madeva C. Sharma;Joy Martinez;Wahajul Haq

  • Predominant type 1 CMV-specific memory T-helper response in humans: evidence for gender differences in cytokine secretion.

    Maria C Villacres;Jeff Longmate;Catherine Auge;Don J Diamond

  • Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.

    Céline A. Blache;Edwin R. Manuel;Teodora I. Kaltcheva;Andrea N. Wong

  • The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation

    John A. Zaia;Joel Y. Sun;Ghislaine M. Gallez-Hawkins;Lia Thao

  • Effects of rat growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells

    Junichi Fukata;Don J. Diamond;Joseph B. Martin

  • Recombinant Modified Vaccinia Virus Ankara Expressing a Soluble Form of Glycoprotein B Causes Durable Immunity and Neutralizing Antibodies against Multiple Strains of Human Cytomegalovirus

    Zhongde Wang;Corinna La Rosa;Rebecca Maas;Heang Ly

  • Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.

    Simon F Lacey;Maria C Villacres;Corinna La Rosa;Zhongde Wang

  • Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting Salmonella-Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors

    Edwin R. Manuel;Céline A. Blache;Rebecca Paquette;Teodora I. Kaltcheva

  • Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries

    Corinna La Rosa;Corinna La Rosa;Corinna La Rosa;Radhika Krishnan;Radhika Krishnan;Radhika Krishnan;Susan Markel;Susan Markel;Susan Markel;Jonathan P. Schneck;Jonathan P. Schneck;Jonathan P. Schneck

Frequent Co-Authors

Simon F. Lacey
Simon F. Lacey University of Pennsylvania
John A. Zaia
John A. Zaia City Of Hope National Medical Center
Stephen J. Forman
Stephen J. Forman City Of Hope National Medical Center
Peter A. Barry
Peter A. Barry Royal Marsden NHS Foundation Trust
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
William J. Britt
William J. Britt University of Alabama at Birmingham
Ajit P. Limaye
Ajit P. Limaye University of Washington
Jeffrey S. Miller
Jeffrey S. Miller University of Minnesota
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Ellis L. Reinherz
Ellis L. Reinherz Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students passionate about Immunology, exploring related healthcare fields can open diverse career opportunities. Many professionals consider nursing as a complementary pathway, given its close interaction with immunological research and patient care. Those without a nursing background might find online ABSN programs for non nurses an accessible starting point, allowing them to enter the nursing field more quickly.

When searching for programs, prospective students often prioritize ease of admission. Programs with the reputation of being the easiest ABSN program to get into provide a smoother transition for those looking to shift their career path without prolonged barriers.

For those interested in practical nursing roles, the fastest and easiest LPN programs can be a strategic choice, offering hands-on training that supports immunology-related healthcare services.

Advanced nursing roles, such as nurse practitioners, also play integral roles in immunological healthcare delivery. Many students find success through nurse practitioner programs with easy admission, which balance competitive curricula with accessible entry requirements.

Best Scientists Citing Don J. Diamond

Trending Scientists